Bill C-275 (Historical)
An Act to amend the Patent Act (infringement of a patent)
This bill was last introduced in the 40th Parliament, 3rd Session, which ended in March 2011.
This bill was previously introduced in the 40th Parliament, 2nd Session.
Brian Masse NDP
Introduced as a private member’s bill. (These don’t often become law.)
Introduced, as of Jan. 29, 2009
(This bill did not become law.)
This is from the published bill. The Library of Parliament often publishes better independent summaries.
This enactment excludes medicines from the scope of the regulation-making power set out in subsection 55.2(4) of the Patent Act. It makes other amendments to that Act to reduce the extent of patent protection for medicines.
The enactment also repeals the Patented Medicines (Notice of Compliance) Regulations.
January 29th, 2009 / 10:15 a.m.
Brian Masse Windsor West, ON
moved for leave to introduce Bill C-275, An Act to amend the Patent Act (infringement of a patent).
Mr. Speaker, drug prices are rising quickly in Canada and although our drug prices are still lower than some other OECD nations, ours are rising faster than all those other countries. For example, drug costs have increased by close to 300% between 1985 and 2000.
We would actually mirror a system that has been changed in the United States. We would stop the automatic injunctions right now, where generic drugs are blocked to get on to the market; something that even President Bush fixed over in the American system. That just shows members how extreme the Canadian model is right now. We are behind the Bush administration in terms of changing and protecting its consumers in the United States.
I would ask that this government support this bill, so that we can make sure that drug costs are brought to bear and we can actually put money toward our health care system in a better and more efficient way.
(Motions deemed adopted, bill read the first time and printed)